Catalyst
Slingshot members are tracking this event:
FDA Delays Initiation of Inovio's (INO) Phase 3 Program Evaluating VGX-3100 in HPV-Related Cancers, Requests Additional Information
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| INO |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Oct 24, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Additional Information, Hpv-related Cancers, Vgx-3100, Phase 3, Initiation, Delay, Fda
